The role of carcinoembryonic antigen monitoring in management of colorectal cancer

Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology reports 1999, Vol.1 (2), p.168-172
Main Authors: Mulcahy, M F, Benson, 3rd, A B
Format: Article
Language:English
Subjects:
Biomarkers, Tumor - blood
Carcinoembryonic Antigen - blood
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - prevention & control
Colorectal Neoplasms - therapy
Guidelines as Topic
Humans
Mass Screening - methods
Perioperative Care
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Carcinoembryonic antigen (CEA) is an important tool in the management of colorectal cancer. Its use as a prognostic indicator in resectable disease remains controversial but may be improved with molecular detection of the antigen. In monitoring patients after resection, CEA can be the first sign of a potentially curable recurrence. It can also be useful in assessing tumor response in patients being treated for metastases without easily measurable disease. CEA alone cannot dictate the type or duration of treatment but may be used in addition to standard monitoring tests.
ISSN:1523-3790
1534-6269
DOI:10.1007/s11912-999-0029-z